Pages that link to "Q57991151"
Jump to navigation
Jump to search
The following pages link to COMPLICATED URINARY TRACT INFECTIONS (Q57991151):
Displaying 27 items.
- Uropathogen resistance: are laboratory-generated data reliable enough? (Q31101643) (← links)
- The influence of diabetes mellitus on the spectrum of uropathogens and the antimicrobial resistance in elderly adult patients with urinary tract infection (Q33236904) (← links)
- The quinolones and renal infection (Q33770153) (← links)
- Management of pyelonephritis and upper urinary tract infections (Q33786330) (← links)
- Approach to urinary tract infections (Q33873919) (← links)
- Urinary tract infections in adults with diabetes. (Q34214103) (← links)
- Urinary tract infections in patients with diabetes (Q34735146) (← links)
- Management of bacterial urinary tract infections in adult patients with diabetes mellitus (Q34820294) (← links)
- Novel approaches to prevention of urinary tract infections (Q35171788) (← links)
- Propensity-matched analysis to compare the therapeutic efficacies of cefuroxime versus cefotaxime as initial antimicrobial therapy for community-onset complicated nonobstructive acute pyelonephritis due to Enterobacteriaceae infection in women (Q35385843) (← links)
- Change of Antimicrobial Susceptibility amongEscherichia coliStrains Isolated from Female Patients with Community-Onset Acute Pyelonephritis (Q35648288) (← links)
- Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections (Q35807260) (← links)
- Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis (Q35971059) (← links)
- Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli (Q36461110) (← links)
- Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis (Q37052814) (← links)
- Efficacy and safety of ciprofloxacin XR 1000 mg once daily versus ciprofloxacin 500 mg twice daily in the treatment of complicated urinary tract infections (Q43195355) (← links)
- A randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis (Q43930297) (← links)
- Urinary tract infection in women: new pathogenic considerations. (Q54453049) (← links)
- Urinary tract infection in adults: research priorities and strategies (Q57991131) (← links)
- A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections (Q63833156) (← links)
- Polyacrylate Polyalcohol Copolymer for Vesicoureteral Reflux (Q64621491) (← links)
- Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections (Q64676743) (← links)
- A Study of Efficacy/Safety of Intravenous S-649266 Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections (Q65353810) (← links)
- Comparative Study of Coadministered Ceftaroline Fosamil and NXL104 vs. Intravenous Doripenem in Adult Subjects With Complicated Urinary Tract Infections (Q65375521) (← links)
- Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis (Q65542775) (← links)
- A Comparison of the Effectiveness and Safety of Levofloxacin to That of Ciprofloxacin in Treating Complicated Urinary Tract Infection and Acute Pyelonephritis. (Q65545743) (← links)
- Efficacy of Intravenous Fosfomycin in the Treatment of Complicated Urinary in Real-life Conditions. (Q74285694) (← links)